Elizabeth Bruckheimer
Hoofd Techniek/Wetenschap/O&O bij PANBELA THERAPEUTICS, INC.
Profiel
Elizabeth Bruckheimer is currently the Chief Scientific Officer & Vice President at Panbela Therapeutics, Inc. She previously worked as the Director-Preclinical Development at Champions Oncology, Inc. and as the VP-Drug Development & Regulatory Affairs at Cancer Prevention Pharmaceuticals, Inc. She also worked as an Associate Director & Manager at Systems Medicine, Inc. Dr. Bruckheimer holds a doctorate degree from The University of Texas at Austin and an undergraduate degree from the University of Arizona.
Actieve functies van Elizabeth Bruckheimer
| Bedrijven | Functie | Begin |
|---|---|---|
| PANBELA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2022 |
Eerdere bekende functies van Elizabeth Bruckheimer
| Bedrijven | Functie | Einde |
|---|---|---|
| CANCER PREVENTION PHARMACEUTICALS INC | Corporate Officer/Principal | 01-01-2022 |
Systems Medicine, Inc.
 Systems Medicine, Inc. Pharmaceuticals: OtherHealth Technology Systems Medicine, Inc. develops oncology products by integrating predictive cellular pharmacogenomics. The company is based in Tucson, AZ. The company was founded by Jeffrey E. Jacob. Systems Medicine was acquired by CTI BioPharma Corp. on July 31, 2007 for $35 million. | Corporate Officer/Principal | - |
| CHAMPIONS ONCOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Elizabeth Bruckheimer
| University of Arizona | Undergraduate Degree |
| The University of Texas at Austin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CHAMPIONS ONCOLOGY, INC. | Health Technology |
| PANBELA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Systems Medicine, Inc.
Systems Medicine, Inc. Pharmaceuticals: OtherHealth Technology Systems Medicine, Inc. develops oncology products by integrating predictive cellular pharmacogenomics. The company is based in Tucson, AZ. The company was founded by Jeffrey E. Jacob. Systems Medicine was acquired by CTI BioPharma Corp. on July 31, 2007 for $35 million. | Health Technology |
Cancer Prevention Pharmaceuticals, Inc.
 Cancer Prevention Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cancer Prevention Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of therapeutic agents for the treatment and prevention of certain pre-cancerous conditions, orphan diseases and gastrointestinal conditions. The company’s pipeline consists of Gastrointestinal and Orphan. Cancer Prevention Pharmaceuticals was founded by Dr. Frank Meyskens and Gene Gerner in June 9, 2008 and is headquartered in Tucson, AZ. | Health Technology |